Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04250545 |
| Title | Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope Comprehensive Cancer Center | RECRUITING | Duarte | California | 91010 | United States | Details |
| City of Hope at Irvine Lennar | RECRUITING | Irvine | California | 92618 | United States | Details |
| Keck Medicine of USC Koreatown | RECRUITING | Los Angeles | California | 90020 | United States | Details |
| Los Angeles General Medical Center | RECRUITING | Los Angeles | California | 90033 | United States | Details |
| USC / Norris Comprehensive Cancer Center | RECRUITING | Los Angeles | California | 90033 | United States | Details |
| University of California Davis Comprehensive Cancer Center | RECRUITING | Sacramento | California | 95817 | United States | Details |
| Memorial Sloan Kettering Cancer Center | RECRUITING | New York | New York | 10065 | United States | Details |